Erik Løkkevik

Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy

Inger-Lise Nesvold, Alv A. Dahl, Erik Løkkevik et al. · Acta Oncologica · 2008 · 190 citations · Full text

Medicine, Oncology, Surgery +17

The MDM2 Promoter SNP285C/309G Haplotype Diminishes Sp1 Transcription Factor Binding and Reduces Risk for Breast and Ovarian Cancer in Caucasians

Stian Knappskog, Merete Bjørnslett, Line M. Myklebust et al. · Cancer Cell · 2011 · 115 citations · Full text

Life Sciences, Genetics, Molecular Genetics +8

Skin Treatment with Bepanthen Cream Versus No Cream During Radiotherapy: A randomized controlled trial

Erik Løkkevik, Eva Skovlund, Jon B. Reitan et al. · Acta Oncologica · 1996 · 109 citations · Full text

Medicine, Oncology, Radiation Oncology +9

Predictive and Prognostic Impact of TP53 Mutations and MDM2 Promoter Genotype in Primary Breast Cancer Patients Treated with Epirubicin or Paclitaxel

Ranjan Chrisanthar, Stian Knappskog, Erik Løkkevik et al. · PLoS ONE · 2011 · 107 citations · Full text

Medicine, Oncology, Pharmacology +17

Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: A randomised, placebo-controlled study

Jürgen Geisler, Per Eystein Lønning, Lars Erik Krag et al. · European Journal of Cancer · 2006 · 100 citations

Medicine, Endocrinology, Oncology +16